HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Woodcock’s Message To OTC Industry: Innovation, Innovation, Innovation

This article was originally published in The Tan Sheet

Executive Summary

Across the board innovation ranging from manufacturing to Rx switch programs is necessary for the OTC industry to spur growth in the future, according to FDA Acting Deputy Commissioner for Operations Janet Woodcock, MD

You may also be interested in...

Return of the Switch? A Fallow 2005 Sowed the Seeds for Future Switches

A Building Yea

Senate Hearings Probe FDA Authority On Drug Label Changes, Safety Trials

Giving FDA the authority to require changes to drug labeling could help the agency get drug safety information to the public more quickly, FDA Office of New Drugs Deputy Director Sandra Kweder told the Senate Health Committee March 1

FDA OTC Head Ganley Talks Third Class, Plan B And Drug Switches

This spring, FDA's Division of OTC Drug Products will be elevated to full office status within the Center for Drug Evaluation & Research. OTC Division Director Charles Ganley, MD, sat down with "The Tan Sheet" on Dec. 17 to discuss the ramifications of the organizational change, as well as hot-button issues such as the current Rx-to-OTC switch environment, possible monograph system improvements and advisory committee reviews.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts